Publications by authors named "Thomas Shum"

Claim this Profile
P
Phase I Trial of GD2.CART Cells Augmented With Constitutive Interleukin-7 Receptor for Treatment of High-Grade Pediatric CNS Tumors.
Frank Y Lin, Austin Stuckert, Candise Tat, Mark White, Lucia Ruggieri, Thomas Shum, Angshumoy Roy

J Clin Oncol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Constitutive Interleukin-7 Cytokine Signaling Enhances the Persistence of Epstein-Barr Virus-Specific T-Cells.
Sandhya Sharma, Tim Sauer, Bilal A Omer, Thomas Shum, Lisa A Rollins

Int J Mol Sci· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imaging Findings of Thoracic Lymphatic Abnormalities.
Jingshuo Derek Sun, Thomas Shum, Fardad Behzadi, Mark M Hammer

Radiographics· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Costimulatory CAR Improves TCR-based Cancer Immunotherapy.
Bilal Omer, Mara G Cardenas, Thomas Pfeiffer, Rachel Daum, Mai Huynh, Thomas Shum

Cancer Immunol Res· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endoscopic-mediated, biliary hydrodynamic injection mediating clinically relevant levels of gene delivery in pig liver.
Robert L Kruse, Yuting Huang, Thomas Shum, Lu Bai, Hui Ding

Gastrointest Endosc· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determinants of Chest X-Ray Sensitivity for COVID- 19: A Multi-Institutional Study in the United States.
Stephanie Stephanie, Thomas Shum, Heather Cleveland, Suryanarayana R Challa, Allison Herring

Radiol Cardiothorac Imaging· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adult and Cord Blood-Derived High-Affinity gB-CAR-T Cells Effectively React Against Human Cytomegalovirus Infections.
Henning Olbrich, Sebastian J Theobald, Constanze Slabik, Laura Gerasch, Andreas Schneider, Thomas Shum

Hum Gene Ther· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retraction Note: A homing system targets therapeutic T cells to brain cancer.
Heba Samaha, Antonella Pignata, Kristen Fousek, Jun Ren, Fong W Lam, Thomas Shum

Nature· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chimeric Antigen Receptor Signaling Domains Differentially Regulate Proliferation and Native T Cell Receptor Function in Virus-Specific T Cells.
Bilal Omer, Paul A Castillo, Haruko Tashiro, Thomas Shum, Mai T A Huynh

Front Med (Lausanne)· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A homing system targets therapeutic T cells to brain cancer.
Heba Samaha, Antonella Pignata, Kristen Fousek, Jun Ren, Fong W Lam, Thomas Shum

Nature· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A backpack revs up T-cell activity.
Thomas Shum, Helen E Heslop

Nat Biotechnol· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Strategies for enhancing adoptive T-cell immunotherapy against solid tumors using engineered cytokine signaling and other modalities.
Thomas Shum, Robert L Kruse, Cliona M Rooney

Expert Opin Biol Ther· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HBsAg-redirected T cells exhibit antiviral activity in HBV-infected human liver chimeric mice.
Robert L Kruse, Thomas Shum, Haruko Tashiro, Mercedes Barzi, Zhongzhen Yi

Cytotherapy· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In Situ Liver Expression of HBsAg/CD3-Bispecific Antibodies for HBV Immunotherapy.
Robert L Kruse, Thomas Shum, Xavier Legras, Mercedes Barzi, Frank P Pankowicz

Mol Ther Methods Clin Dev· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Constitutive Signaling from an Engineered IL7 Receptor Promotes Durable Tumor Elimination by Tumor-Redirected T Cells.
Thomas Shum, Bilal Omer, Haruko Tashiro, Robert L Kruse, Dimitrios L Wagner

Cancer Discov· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of Acute Myeloid Leukemia with T Cells Expressing Chimeric Antigen Receptors Directed to C-type Lectin-like Molecule 1.
Haruko Tashiro, Tim Sauer, Thomas Shum, Kathan Parikh, Maksim Mamonkin

Mol Ther· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive Approach for Identifying the T Cell Subset Origin of CD3 and CD28 Antibody-Activated Chimeric Antigen Receptor-Modified T Cells.
Michael Schmueck-Henneresse, Bilal Omer, Thomas Shum, Haruko Tashiro, Maksim Mamonkin

J Immunol· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Photo quiz. To scan or not to scan?
Dimitrios Farmakiotis, Kelly Sharon Chien, Thomas Chung Tong Shum, Maria Rodriguez-Barradas, Daniel M Musher

Clin Infect Dis· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced detection of olefins using ambient ionization mass spectrometry: Ag+ adducts of biologically relevant alkenes.
Ayanna U Jackson, Thomas Shum, Ewa Sokol, Allison Dill, R Graham Cooks

Anal Bioanal Chem· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis